Case report: Successful use of mepolizumab for immune checkpoint inhibitors-induced hypereosinophilic syndrome in two patients with solid malignancies.

Lazzari, Chiara; Yacoub, Mona Rita; Campochiaro, Corrado; Bulotta, Alessandra; Palumbo, Diego; Ogliari, Francesca Rita; Dagna, Lorenzo; Marchesi, Silvia; Ponzoni, Maurilio; Gregorc, Vanesa

Lazzari, Chiara; Yacoub, Mona Rita; Campochiaro, Corrado; Bulotta, Alessandra; Palumbo, Diego; Ogliari, Francesca Rita; Dagna, Lorenzo; Marchesi, Silvia; Ponzoni, Maurilio; Gregorc, Vanesa.

Afiliação

Lazzari C; Department of Oncology, Candiolo Cancer Institute Fondazione Piemontese per l'Oncologia-Istituto di Ricerca a Carattere Scientifico (FPO-IRCCS) Candiolo, Torino, Italy.
Yacoub MR; Department of Rheumatology and Clinical Immunology, Istituto di Ricerca a Carattere Scientifico (IRCCS) San Raffaele Hospital, Milano, Italy.
Campochiaro C; Department of Rheumatology and Clinical Immunology, Istituto di Ricerca a Carattere Scientifico (IRCCS) San Raffaele Hospital, Milano, Italy.
Bulotta A; Department of Oncology, Istituto di Ricerca a Carattere Scientifico (IRCCS) San Raffaele Hospital, Milano, Italy.
Palumbo D; Department of Radiology, Istituto di Ricerca a Carattere Scientifico (IRCCS) San Raffaele Hospital, Milano, Italy.
Ogliari FR; Department of Oncology, Istituto di Ricerca a Carattere Scientifico (IRCCS) San Raffaele Hospital, Milano, Italy.
Dagna L; Department of Rheumatology and Clinical Immunology, Istituto di Ricerca a Carattere Scientifico (IRCCS) San Raffaele Hospital, Milano, Italy.
Marchesi S; Department of Oncology, Candiolo Cancer Institute Fondazione Piemontese per l'Oncologia-Istituto di Ricerca a Carattere Scientifico (FPO-IRCCS) Candiolo, Torino, Italy.
Ponzoni M; Vita-Salute San Raffaele University, Milano, Italy.
Gregorc V; Pathology Unit, Istituto di Ricerca a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy.